Is Trending Stock Hologic, Inc. ( HOLX ) a Buy Now?
Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Hologic Eyes Organic Growth Rebound in 2026 on Breast Health Strength
HOLX targets a mid-single-digit organic growth rebound in 2026, powered by Breast Health recovery and new product innovation.
Hologic's Diagnostics Arm Set for Long-Term Upside: What's Behind It?
HOLX's Diagnostics arm eyes long-term growth with new assays, platform expansion and oncology test adoption despite headwinds.
Should You Buy, Sell or Hold Hologic Stock Post Q3 Earnings?
HOLX rises post earnings beat, fueled by Diagnostics strength and Surgical growth. However, macro headwinds persist.
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Tempus AI Targets Breast Cancer With Expanded Next - AI Platform
TEM expands its AI-driven Tempus Next platform into breast cancer, targeting key testing gaps to improve care delivery.
Why Hologic ( HOLX ) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Interpreting Hologic ( HOLX ) International Revenue Trends
Evaluate Hologic's (HOLX) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
Hologic, Inc. ( HOLX ) is Attracting Investor Attention: Here is What You Should Know
Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Hologic Stock Falls Despite Q3 Earnings and Revenue Beat, Margins Down
HOLX posts better-than-expected Q3 results, but margin contraction and regional headwinds pressure investor sentiment.
Hologic ( HOLX ) Q3 Revenue Beats 1%
Hologic ( NASDAQ:HOLX ) , a global medical technology company specializing in diagnostics and women's health, reported financial results for the third quarter of fiscal 2025 on July 30, 2025. The most notable headline: both GAAP revenue and non-GAAP earnings per share came in ahead of ...
Hologic ( HOLX ) Q3 Earnings and Revenues Beat Estimates
Hologic (HOLX) delivered earnings and revenue surprises of +2.86% and +1.68%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Hologic Focuses on Breast Health Turnaround This Year: Can It Deliver?
HOLX eyes a Breast Health rebound in Q4, backed by leadership changes, new strategy and Endomag momentum.
Seeking Clues to Hologic ( HOLX ) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics
Get a deeper insight into the potential performance of Hologic (HOLX) for the quarter ended June 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
HOLX vs. EXAS: Which Cancer Diagnostics Stock Should You Retain Now?
EXAS gains edge over HOLX as rising Cologuard adoption, new launches and bullish EPS trends boost investor appeal.
Hologic's International Momentum Takes Shape: Will Execution Pay Off?
HOLX is leaning into international growth with Surgical division strength and untapped demand driving momentum abroad.
Hologic ( HOLX ) Laps the Stock Market: Here's Why
In the closing of the recent trading day, Hologic (HOLX) stood at $65.37, denoting a +2.64% move from the preceding trading day.
Is Hologic Stock a Risky Investment Ahead of Its Q3 Earnings Report?
HOLX heads into Q3 earnings with revenue and EPS estimates down, tariff pressures mounting, and stock lagging peers.
Looking Into Hologic's Recent Short Interest - Hologic ( NASDAQ:HOLX )
Hologic's HOLX short percent of float has risen 10.85% since its last report. The company recently reported that it has 5.58 million shares sold short, which is 3.27% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.97 days to cover their ...
Hologic Rides on AI-Powered Breast Health Innovations: What's Next?
HOLX advances breast health with AI tools like Genius Detection PRO and the upcoming Envision 3D platform.
Why Hologic ( HOLX ) Dipped More Than Broader Market Today
The latest trading day saw Hologic (HOLX) settling at $63.26, representing a -2.1% change from its previous close.
Hologic, Inc. ( HOLX ) Is a Trending Stock: Facts to Know Before Betting on It
Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.
Hologic's GYN Surgical Dominance: What's Powering the Road Ahead?
HOLX's GYN Surgical arm gains momentum with Fluent Pro, global expansion and strategic acquisitions fueling growth.
Hologic ( HOLX ) Surpasses Market Returns: Some Facts Worth Knowing
In the latest trading session, Hologic (HOLX) closed at $65.85, marking a +1.46% move from the previous day.
Is Hologic Stock's Low Valuation an Opportunity or a Value Trap?
HOLX trades below peers on P/S, but falling EPS, weak Breast Health sales and China risks cloud the outlook.
Hologic, Inc. ( HOLX ) is Attracting Investor Attention: Here is What You Should Know
Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.
JANNIK SINNER AND CARLOS ALCARAZ LEAD TOP 73 PLAYERS IN THE WORLD TO TORONTO FOR THE 2025 NATIONAL BANK OPEN
The tournament expands to a 12-day format, and will be held at Sobeys Stadium from July 26-August 7 Canadians Félix Auger-Aliassime, Denis Shapovalov, and Gabriel Diallo are among the star-studded player field
Hologic Faces Molecular Drag, But Here's Why It's Not a Major Concern
HOLX's Molecular Diagnostics growth stays resilient, as new assays and test adoption offset funding headwinds.
Hologic ( HOLX ) Surpasses Market Returns: Some Facts Worth Knowing
In the most recent trading session, Hologic (HOLX) closed at $65.11, indicating a +1.31% shift from the previous trading day.
How Hologic Leverages Its Financial Firepower to Drive Long-Term Value
Backed by robust profitability, HOLX deploys billions into acquisitions and repurchases to boost future earnings.
Is the Market Bullish or Bearish on Hologic? - Hologic ( NASDAQ:HOLX )
Hologic's HOLX short percent of float has fallen 29.41% since its last report. The company recently reported that it has 5.11 million shares sold short, which is 3.0% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.03 days to cover their ...
HOLX vs. COO: Which GYN Surgical Stock Is the Better Investment Now?
As demand for GYN surgical tools climbs, HOLX and COO battle it out. Find out which stock shows stronger growth momentum now.
Hologic, Inc. ( HOLX ) Is a Trending Stock: Facts to Know Before Betting on It
Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Hologic ( HOLX ) Suffers a Larger Drop Than the General Market: Key Insights
Hologic (HOLX) concluded the recent trading session at $64.14, signifying a -1.6% move from its prior day's close.
Hologic's Margin Stability Amid Tariffs: What's Behind the Confidence?
HOLX lifts margins despite tariffs and weak China sales, leaning on diagnostics strength and high-margin buys.
Can Hologic Lean on Its Strengths in a Tough Macroeconomic Climate?
HOLX grapples with global headwinds, but growth in Diagnostics and Breast Health service lifts confidence.
Investors Heavily Search Hologic, Inc. ( HOLX ) : Here is What You Need to Know
Zacks.com users have recently been watching Hologic (HOLX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Hologic Climbs 13% in a Month: How Should You Play the Stock?
HOLX up 13% over the last month, supported by a rejected $16.7 billion buyout offer and new BCI data. What's the investment outlook?
Hologic Navigates Breast Health Slump: Is the Growth Thesis Intact?
HOLX weathers Breast Health softness with rising service revenues, the Endomag acquisition and new tech on the horizon.
Deal Dispatch: Beauty Brand Seeks Pretty Price Tag, Behavioral Health Firms Hit Auction Block - EOG Resources ( NYSE:EOG ) , e.l.f. Beauty ( NYSE:ELF )
Revolution explores a sale following its CEO's exit, while e.l.f. entices Hailey Bieber with a $1 billion deal. New data suggests that, after several volatile years, the behavioral health sector is regaining favor among strategic and financial buyers.
Here is What to Know Beyond Why Hologic, Inc. ( HOLX ) is a Trending Stock
Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Why Is Diagnostic Firm Hologic Stock Trading Higher On Tuesday? - Hologic ( NASDAQ:HOLX )
TPG and Blackstone's bid valued Hologic at $70-$72 per share, a premium to its $54.28 closing price. Hologic's share price has declined 24% in 2024 amid tariff challenges and weakening demand. Get stock picks, daily rankings, and pro-level trading tools in one powerful platform-now 60% off for ...
HOLX vs. DGX: Which Women's Health-Focused Stock Is the Better Pick?
The women's health market is booming, with Hologic and Quest Diagnostics leading the charge. But which one stands out more for investors today?
Guerbet : Changes in the composition of the Guerbet board of directors.
CHANGES IN THE COMPOSITION OF THE GUERBET BOARD OF DIRECTORS ...
Is the Market Bullish or Bearish on Hologic? - Hologic ( NASDAQ:HOLX )
Hologic's HOLX short percent of float has fallen 20.1% since its last report. The company recently reported that it has 5.35 million shares sold short, which is 3.14% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.05 days to cover their ...
Is Trending Stock Hologic, Inc. ( HOLX ) a Buy Now?
Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.
Understanding Hologic ( HOLX ) Reliance on International Revenue
Evaluate Hologic's (HOLX) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
Tariffs Dim Hologic's 2025 Expectations: Time to Reassess the Stock?
HOLX displays cautious fiscal 2025 guidance in a challenging geopolitical and macroeconomic environment. What does it mean for the stock?
Hologic, Inc. ( HOLX ) is Attracting Investor Attention: Here is What You Should Know
Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.
